Kellen Mulhern, DO
Critical Care Medicine · Washington, DCNPI 1043668437
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,522 of the $9,968 with a category attached, or 75.5%. Intuitive Surgical accounts for 93.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $7,157 and has fallen 70.7% since, to $2,095 in 2025. Among critical care medicine clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $216.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Regeneron Healthcare Solutions, Inc.$156
- GSK$121
- Mylan Specialty L.p.$119
- Inspire Medical Systems, Inc.$117
- Pulmonx Corporation$85
- plus $78 from 2 others
What the payments were for
- Travel & lodging$1,29513%
- Food & beverage$1,15112%
- Education$7,52275%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 26 | $9,292 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| GSK | 6 | $121 |
| Mylan Specialty L.p. | 1 | $119 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Pulmonx Corporation | 1 | $85 |
| AstraZeneca | 3 | $62 |
| Vifor Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,968 in reported general payments places this provider in the 90th percentile of 59 critical care medicine providers in District of Columbia.
See all critical care medicine providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 105 | $80,900 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 74 | $48,794 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 18 | $8,969 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $8,358 |
| Incruse ElliptaUmeclidinium Bromide | 21 | $7,097 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,523 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,991 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $4,013 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 20 | $2,783 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 56 | $1,248 |
| Fluticasone Propionate | 15 | $214 |
| Prednisone | 21 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $121 | $92,988137 claims |
| AstraZenecaBreztri Aerosphere | $62 | $48,79474 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 59 critical care medicine providers in District of Columbia.
Other critical care medicine in Washington
- Lakhmir ChawlaWashington$441K
- Jonathan ChowWashington$285K
- Tunay KuruWashington$81K
- Vivek JainWashington$14K
- Jacob CollenWashington$8K
- Danielle DavisonWashington$5K
- Andrew HillWashington$5K
- Dina KianouryWashington$5K
- Brian LeeWashington$3K
- Pramod BhattaraiWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.